echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical Science News > Shanghai No. 10 Hospital found that propofol, a commonly used intravenous anesthetic, may cause tumor invasion

    Shanghai No. 10 Hospital found that propofol, a commonly used intravenous anesthetic, may cause tumor invasion

    • Last Update: 2021-08-01
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com


    Professor Yuan Shen, Director of the Department of Psychiatry, Shanghai Tenth People’s Hospital and Executive Deputy Director of the Institute of Anesthesia and Brain Function, Tongji University School of Medicine, and Professor Xie Zhongcong, Director of the Geriatric Anesthesia Laboratory of the Massachusetts General Hospital of Harvard University in the United States, through a series of in vivo, In vitro experiments have confirmed from multiple levels of molecules, proteins, tissues, etc.


    Or increase tumor invasion/metastasis


    To this end, the researchers took colon cancer cells as the main research object, and modeled the injection of propofol into the tail vein of mice while injecting colon cancer cells to simulate the contact between propofol and intravascular circulating tumor cells during the clinical perioperative period.


    At the same time, the research team used another GABAAR-specific agonist, Muscimol, to pre-treat tumor cells in vitro and then injected them into the body.


    Successful adhesion to vascular endothelial cells is a key link in the metastasis of circulating tumor cells


    Based on this, the researchers further locked the important target for the development of anti-cancer drugs, and at the same time an important proto-oncogene-Src kinase that mediates cell adhesion


    This discovery has very important clinical significance in the fields of anesthesiology, oncology and surgery


    Related paper information: http://doi.


    http://doi.
    org/10.
    1002/advs.
    202102079
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.